The WHO BPaLM Accelerator Platform was established in January 2023, right after the update of the World Health Organization (WHO) guidelines on the treatment of drug-resistant TB in 2022. The purpose of the WHO BPaLM Accelerator Platform is to support countries and stakeholders in information exchange and technical discussions to address challenges in the adoption and implementation of the BPaLM/BPaL regimen (consisting of bedaquiline, pretomanid, linezolid and moxifloxacin, with the provision of dropping moxifloxacin in case of confirmed resistance to fluoroquinolones). This is also to support the Call to Action on rolling out of the BPaLM regimen and other short regimens for treatment of drug-resistant TB that was initiated by WHO and its multiple partners. 

The 1/4/6x24 Campaign and the Stop TB Partnership co-hosted a webinar on 27 March 2024 to launch the Campaign’s new report: Getting Better Faster: Delivering on the Promise of New TB Treatments. The report highlights progress and gaps in scaling up access to shorter, safer TB regimens — one month or once weekly for TB prevention, four months for drug-susceptible TB, and six months for drug-resistant TB — by the end of 2024.

The Philippines has the fourth highest TB burden in the world and contributes 7% of global cases, behind India (27%), Indonesia (10%), and China (7.1%), according to the World Health Organization’s Global TB Report 2021. But for the archipelagic country with 7,640 islands, citizens’ access to healthcare and diagnostic tools has been one of the greatest barriers to addressing TB.

With less than a year to go until the 1/4/6x24 Campaign deadline, the Getting Better Faster: Delivering on the Promise of New TB Treatments report outlines both progress made and remaining gaps toward achieving 1/4/6x24.

The TB Vax ARM outlines three key advocacy wins for the field to achieve by 2026 in order to effectively advance TB vaccine development. Check them out and sign a petition to show your support!

TB advocates protest outside the headquarters of Danaher in Washington, DC, demanding price drop to $5 per test.

Médecins Sans Frontières (MSF) Access Campaign will host a webinar on 5 March 2024 to provide an update about the next phase of escalation of the Time for $5 Campaign.

A consensus statement provides a framework for ensuring that pregnant and breastfeeding women and persons are better served by TB research and can fully benefit from scientific advancements in the prevention and treatment of TB.

A story tells how the endTB project has improved TB care through a series of scientific studies while pushing the boundaries of what’s thought possible: in clinical trials, in epidemiology, and in the thinking about where you can do the science required to deliver world-class health care where it’s needed most.

The patent opposition was submitted by the Indonesia AIDS Coalition and Indonesia for Global Justice in November 2022 and was rejected by a decision from the Judiciary Panel on 9 November 2023.